Insider Transactions in Q3 2024 at Haemonetics Corp (HAE)
Insider Transaction List (Q3 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 17
2024
|
Laurie A. Miller SVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
238
-1.32%
|
$18,088
$76.54 P/Share
|
Aug 29
2024
|
Simon, Christopher President & CEO |
SELL
Other acquisition or disposition
|
Direct |
39,704
-10.95%
|
$2,977,800
$75.56 P/Share
|
Jul 26
2024
|
Stewart W Strong President, Global Hospital |
SELL
Open market or private sale
|
Direct |
4,312
-19.16%
|
$392,392
$91.15 P/Share
|
Jul 25
2024
|
Stewart W Strong President, Global Hospital |
SELL
Payment of exercise price or tax liability
|
Direct |
2,798
-11.06%
|
$251,820
$90.58 P/Share
|
Jul 25
2024
|
Diane M Bryant Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+33.24%
|
-
|
Jul 25
2024
|
Robert E Abernathy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+9.01%
|
-
|
Jul 25
2024
|
Mark W Kroll Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+9.65%
|
-
|
Jul 25
2024
|
Lloyd Emerson Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+17.73%
|
-
|
Jul 25
2024
|
Charles J Dockendorff Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+33.24%
|
-
|
Jul 25
2024
|
Michael J Coyle Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+14.8%
|
-
|
Jul 25
2024
|
Ellen M Zane Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+11.69%
|
-
|
Jul 25
2024
|
Claire Pomeroy Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,207
+13.47%
|
-
|
Jul 24
2024
|
Stewart W Strong President, Global Hospital |
BUY
Grant, award, or other acquisition
|
Direct |
7,110
+21.93%
|
-
|
Jul 12
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
79
-0.37%
|
$7,110
$90.0 P/Share
|
Jul 11
2024
|
Anila Lingamneni EVP, Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,136
-9.07%
|
$192,240
$90.0 P/Share
|